Skip to main content
Clinical Trials/NCT05624905
NCT05624905
Recruiting
Not Applicable

Prospective Registry for Identifying Long-term Prognosis in Patients Who Underwent Coronary Angiography and Percutaneous Coronary Intervention for Coronary Artery Disease

Samsung Medical Center1 site in 1 country15,000 target enrollmentMarch 20, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
Samsung Medical Center
Enrollment
15000
Locations
1
Primary Endpoint
Rates of Cardiac death or Target-vessel myocardial infarction
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Coronary artery disease is the most important cause of death worldwide. Treatment option for coronary artery disease is medical treatment, percutaneous coronary intervention, or coronary artery bypass surgery. Among them, the field of percutaneous coronary intervention is rapidly developing with regard to the improvement of devices, techniques, or medical treatment, leading to reduce mortality or morbidity. Until now, numerous previous studies related to the risk factors of coronary artery disease and the prognosis of patients have been conducted. However, the field of percutaneous coronary intervention is rapidly evolving, and treatment strategies are constantly being updated. Therefore, the current study sought to identify the long-term prognosis and related risk factors of patients with coronary artery disease who underwent percutaneous coronary intervention.

Registry
clinicaltrials.gov
Start Date
March 20, 2016
End Date
December 31, 2030
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Joo-Yong Hahn

Professor

Samsung Medical Center

Eligibility Criteria

Inclusion Criteria

  • patients who have undergone or are scheduled to undergo coronary angiography and percutaneous coronary intervention.

Exclusion Criteria

  • patients who did not consent to the research

Outcomes

Primary Outcomes

Rates of Cardiac death or Target-vessel myocardial infarction

Time Frame: up to 10 years

A composite of cardiac death or target vessel myocardial infarction

Rates of Major adverse cardiac and cerebrovascular event

Time Frame: up to 10 years

A composite of all-cause death, myocardial infarction, cerebrovascular accident, or repeat revascularization

Secondary Outcomes

  • Rates of cerebrovascular accident(up to 10 years)
  • Rates of cardiac death(up to 10 years)
  • Rates of target vessel revascularization(up to 10 years)
  • Rates of all-cause death(up to 10 years)
  • Rates of target lesion revascularization(up to 10 years)
  • Rates of stent thrombosis(up to 10 years)
  • Rates of myocardial infarction(up to 10 years)
  • Rates of target-vessel myocardial infarction(up to 10 years)

Study Sites (1)

Loading locations...

Similar Trials